Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

284

Full text

230

Free full text

Publication Types

Journal Article

288

Clinical Trial, Phase II

118

Clinical Trial

113

Research Support, Non-U.S. Gov't

106

Multicenter Study

Review

Randomized Controlled Trial

Clinical Trial, Phase I

Comparative Study

Clinical Trial, Phase III

Research Support, U.S. Gov't, P.H.S.

Research Support, N.I.H., Extramural

Meta-Analysis

Systematic Review

Comment

Case Reports

Observational Study

Letter

Validation Study

Research Support, N.I.H., Intramural

Evaluation Study

News

Pragmatic Clinical Trial

Publication Year

From

Quick links

Individual year

2025

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Vinorelbine""[mesh_terms]

292 Results

Searching titles within these results

Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review.

T Takahama, S Tsukamoto, A F Mavrogenis, Y Tanaka, Y Tanaka, C Errani

Musculoskeletal surgery 2023;107(1):7-18

Full Text

Abstract

Vinorelbine in cancer therapy.

Anna Capasso

Current drug targets 2012;13(8):1065-71

Full Text

Abstract

Effect of ethnicity on vinorelbine pharmacokinetics: a population pharmacokinetics analysis.

Aurélie Pétain, Dafang Zhong, Xiaoyan Chen, Zhang Li, Shao Zhimin, Jiang Zefei, Grégoire Zorza, Pierre Ferré

Cancer chemotherapy and pharmacology 2020;84(2):373-382

Free Full Text

Abstract

Activity of vinorelbine in gastrointestinal cancers.

Thierry Conroy

Critical reviews in oncology/hematology 2003;42(2):173-8

Full Text

Abstract

Vinorelbine induced perforation of a metastatic gastric lesion.

W J Mullally, C B O'Súilleabháin, C Brady, S O'Reilly

Irish journal of medical science 2018;186(3):571-575

Free Full Text

Abstract

Oral vinorelbine: role in the management of metastatic breast cancer.

Matti S Aapro, Pierfranco Conte, Emilio Esteban González, Véronique Trillet-Lenoir

Drugs 2007;67(5):657-67

Full Text

Abstract

Effect of Eribulin on Angiogenesis and the Expression of Endothelial Adhesion Molecules.

Andrea Abbona, Matteo Paccagnella, Simonetta Astigiano, Stefania Martini, Nerina Denaro, Fiorella Ruatta, Ottavia Barbieri, Marco Merlano, Ornella Garrone

Anticancer research 2022;42(6):2859-2867

Full Text

Abstract

Single-agent chemotherapy with vinorelbine for pretreated or metastatic squamous cell carcinoma of the esophagus.

S C Stani, P Bidoli, D De Candis, D Cortinovis, H S Parra, E Bajetta

Tumori 2002;87(5):299-302

Full Text

Abstract

Phase II trial of vinorelbine tartrate in patients with treatment-naive metastatic melanoma.

Antonio Jimeno, Ricardo Hitt, Miguel Quintela-Fandino, Hernán Cortés-Funes

Anti-cancer drugs 2005;16(1):53-7

Full Text

Abstract

Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer.

Antonio Rossi, Cesare Gridelli, Vittorio Gebbia, Gerardo Rosati, Anna Tortoriello, Paolo Maione, Nicola Borsellino, Nestore Rossi, Agata Pisano, Giuseppe Colantuoni, Rosario Vincenzo Iaffaioli, Vincenzo Castaldo, Luigi Manzione

Anticancer research 2003;23(2C):1657-64

Full Text

Abstract

Phase I trial of metronomic oral vinorelbine in patients with advanced cancer.

Lakshmi Rajdev, Abdissa Negassa, Qun Dai, Gary Goldberg, Kathy Miller, Joseph A Sparano

Cancer chemotherapy and pharmacology 2011;68(5):1119-24

Full Text

Abstract

Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancer.

R Deporte-Fety, N Simon, P Fumoleau, M Campone, P Kerbrat, J Bonneterre, P Fargeot, S Urien

Cancer chemotherapy and pharmacology 2004;53(3):233-8

Full Text

Abstract

Chemotherapy of non-small cell lung cancer in the elderly.

Cesare Gridelli

Lung cancer (Amsterdam, Netherlands) 2004;38 Suppl 3():S67-70

Full Text

Abstract

The impact of aging on chemotherapy.

Shakun M Malik

Clinical lung cancer 2004;5(4):243-4

Full Text

Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.

K H Yeh, Y S Lu, C H Hsu, J F Lin, H J Chao, T C Huang, C Y Chung, C S Chang, C H Yang, A L Cheng

British journal of cancer 2005;92(6):1013-8

Free Full Text

Abstract

Results: 1 – 15 / 292

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Vinorelbine""[mesh_terms]

Clinical outcomes of medical treatments for progressive desmoid tumors following active surveillance: a systematic review.

Vinorelbine in cancer therapy.

Effect of ethnicity on vinorelbine pharmacokinetics: a population pharmacokinetics analysis.

Activity of vinorelbine in gastrointestinal cancers.

Vinorelbine induced perforation of a metastatic gastric lesion.

Oral vinorelbine: role in the management of metastatic breast cancer.

Effect of Eribulin on Angiogenesis and the Expression of Endothelial Adhesion Molecules.

Single-agent chemotherapy with vinorelbine for pretreated or metastatic squamous cell carcinoma of the esophagus.

Phase II trial of vinorelbine tartrate in patients with treatment-naive metastatic melanoma.

Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer.

Phase I trial of metronomic oral vinorelbine in patients with advanced cancer.

Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancer.

Chemotherapy of non-small cell lung cancer in the elderly.

The impact of aging on chemotherapy.

Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.

Results for
""Vinorelbine""[mesh_terms]